1. A documented 33% dementia chance post-stroke from an Australian study? May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
3. A 20% chance in this research. July 2013.
If you have anything close to a decent doctor a protocol will already be in place to prevent this from occurring.
http://nnr.sagepub.com/content/early/2016/06/29/1545968316656054.abstract
- Walter Swardfager, PhD1,2,3⇑
- Bradley J. MacIntosh, PhD1,2
- 1Sunnybrook Research Institute, Toronto, Ontario, Canada
- 2University of Toronto, Toronto, Ontario, Canada
- 3University Health Network Toronto Rehabilitation Institute, Toronto, Ontario, Canada
- Walter Swardfager, Department of Pharmacology & Toxicology, University of Toronto, 1 King’s College Circle, Toronto, Ontario, M5S 1A8, Canada. Email: w.swardfager@utoronto.ca
Abstract
Background. Ten percent of stroke
survivors develop dementia, which increases to more than a third after
recurrent stroke. Other survivors
develop less severe vascular cognitive impairment.
In the general population, depression, and diabetes interact in
predicting
dementia risk, and they are both prevalent in
stroke. Objective. To assess the cumulative association of comorbid depressive symptoms and type 2 diabetes with cognitive outcomes among stroke
survivors. Methods. Multicenter
observational cohort study of people within 6 months of stroke.
Depression and cognitive status were screened
using the Center for Epidemiological Studies
Depression (CES-D) scale and the Montreal Cognitive Assessment (MoCA),
respectively.
Processing speed, executive function and memory
were assessed using the Trail Making Test parts A and B, and the 5 Word
Delayed
Free Recall task. Results. Among 342
participants (age 67.0 ± 13.5 years, 43.3% female, 46 ± 35 days
poststroke), the prevalence of type 2 diabetes
was 32.2% and depressive symptoms (CES-D ≥16) were
found in 40.6%. Diabetes and depressive symptoms increased the risk of
severe cognitive impairment (MoCA <20) with
adjusted odds ratio (OR) 2.12 (95% confidence interval [CI] 1.20-3.74, P = .010) for 1 comorbidity and OR 3.18 (95% CI 1.26-8.02, P = .014) for both comorbidities. Associated cognitive deficits included executive function (F1, 168 = 3.43, P = .035) but not processing speed (F1, 168 = 1.86, P = .16) or memory (F1, 168 = 0.82, P = .44). Conclusions.
Diabetes and depressive symptoms were associated cumulatively with
poorer cognitive screening outcomes poststroke, particularly
deficits in executive function. Having 1
comorbidity doubled the odds of screening for severe cognitive
impairment, having
both tripled the odds.
No comments:
Post a Comment